Previous Article | Next Article 
Journal of Virology, July 1999, p. 5894-5902, Vol. 73, No. 7
0022-538X/99/$04.00+0
Identification and Rapid Quantification of Early- and Late-Lytic
Human Herpesvirus 8 Infection in Single Cells by Flow Cytometric
Analysis: Characterization of Antiherpesvirus Agents
J. Paul
Zoeteweij,1
Sharon T.
Eyes,2
Jan M.
Orenstein,3
Tatsuyoshi
Kawamura,1
LiJun
Wu,4
Bala
Chandran,5
Bagher
Forghani,4 and
Andrew
Blauvelt1,*
Dermatology Branch, National Cancer
Institute,1 and Howard Hughes Medical
Institute,2 Bethesda, Maryland 20892;
Pathology Department, George Washington University, Washington,
D.C. 200373; Viral and Rickettsial
Disease Laboratory Branch, Division of Communicable Disease Control,
California Department of Health Services, Berkeley, California
947044; and Department of Microbiology,
Molecular Genetics and Immunology, University of Kansas Medical
Center, Kansas City, Kansas 661605
Received 17 February 1999/Accepted 29 March 1999
Human herpesvirus 8 (HHV-8) infection is associated with
Kaposi's sarcoma, primary effusion lymphoma (PEL), and multicentric Castleman's disease. In this study, we used monoclonal antibodies (MAbs) directed against HHV-8 lytic cycle-associated proteins encoded
by open reading frame (ORF) 59 (nuclear PF-8 protein) and ORF K8.1
(viral envelope glycoprotein K8.1 [gpK8.1]) to investigate HHV-8
lytic infection in single cells. Lytically infected cells were labeled
with MAbs, stained with fluorescently conjugated secondary Abs,
and analyzed by flow cytometry. A 3-day stimulation of
HHV-8-positive PEL cell lines (BCBL-1 and BC-3) with
12-O-tetradecanoylphorbol-13-acetate (30 nM) or
n-butyric acid (0.3 mM) maximized the expression of lytic-phase viral proteins and minimized cell toxicity. The absolute number of expressing cells was inducer and cell line dependent. Expression of PF-8 occurred earlier and more frequently (in up to 20%
of cells) than did expression of gpK8.1. A subset of PF-8 positive
cells (25%) co-expressed gpK8.1, representing the majority of gpK8.1
expressing cells. Acyclovir, foscarnet, cidofovir, and PMEA reduced the
number of cells expressing gpK8.1, but not the number expressing the
nonstructural early lytic gene product PF-8. By contrast, alpha
interferon (IFN-
) and IFN-
reduced expression of both PF-8 and
gpK8.1, implying an overall inhibitory effect on viral gene
transcription or translation. In summary, we have characterized and
quantified HHV-8 lytic infection in single cells by dual measurement of
early- and late-lytic-cycle HHV-8 protein expression. This technique
should prove useful for screening of possible antiherpesvirus agents
and for detailed phenotypic characterization of HHV-8-infected cells in
vitro and in patients with HHV-8-associated diseases.
*
Corresponding author. Mailing address: Dermatology
Branch, NCI, Building 10/Room 12N238, 10 Center Dr. MSC 1908, Bethesda, MD 20892-1908. Phone: (301) 402-4167. Fax: (301) 402-1439. E-mail: Andrew_Blauvelt{at}nih.gov
Journal of Virology, July 1999, p. 5894-5902, Vol. 73, No. 7
0022-538X/99/$04.00+0
This article has been cited by other articles:
-
Sander, G., Konrad, A., Thurau, M., Wies, E., Leubert, R., Kremmer, E., Dinkel, H., Schulz, T., Neipel, F., Sturzl, M.
(2008). Intracellular Localization Map of Human Herpesvirus 8 Proteins. J. Virol.
82: 1908-1922
[Abstract]
[Full Text]
-
Davis, D. A., Singer, K. E., Reynolds, I. P., Haque, M., Yarchoan, R.
(2007). Hypoxia Enhances the Phosphorylation and Cytotoxicity of Ganciclovir and Zidovudine in Kaposi's Sarcoma-Associated Herpesvirus Infected Cells. Cancer Res.
67: 7003-7010
[Abstract]
[Full Text]
-
Zeng, Y., Zhang, X., Huang, Z., Cheng, L., Yao, S., Qin, D., Chen, X., Tang, Q., Lv, Z., Zhang, L., Lu, C.
(2007). Intracellular Tat of Human Immunodeficiency Virus Type 1 Activates Lytic Cycle Replication of Kaposi's Sarcoma-Associated Herpesvirus: Role of JAK/STAT Signaling. J. Virol.
81: 2401-2417
[Abstract]
[Full Text]
-
Adang, L. A., Parsons, C. H., Kedes, D. H.
(2006). Asynchronous Progression through the Lytic Cascade and Variations in Intracellular Viral Loads Revealed by High-Throughput Single-Cell Analysis of Kaposi's Sarcoma-Associated Herpesvirus Infection.. J. Virol.
80: 10073-10082
[Abstract]
[Full Text]
-
Dittmer, D. P., Gonzalez, C. M., Vahrson, W., DeWire, S. M., Hines-Boykin, R., Damania, B.
(2005). Whole-Genome Transcription Profiling of Rhesus Monkey Rhadinovirus. J. Virol.
79: 8637-8650
[Abstract]
[Full Text]
-
Gasperini, P., Barbierato, M., Martinelli, C., Rigotti, P., Marchini, F., Masserizzi, G., Leoncini, F., Chieco-Bianchi, L., Schulz, T. F., Calabro, M. L.
(2005). Use of a BJAB-Derived Cell Line for Isolation of Human Herpesvirus 8. J. Clin. Microbiol.
43: 2866-2875
[Abstract]
[Full Text]
-
Lu, C., Zeng, Y., Huang, Z., Huang, L., Qian, C., Tang, G., Qin, D.
(2005). Human Herpesvirus 6 Activates Lytic Cycle Replication of Kaposi's Sarcoma-Associated Herpesvirus. Am. J. Pathol.
166: 173-183
[Abstract]
[Full Text]
-
Deng, J.-H., Zhang, Y.-J., Wang, X.-P., Gao, S.-J.
(2004). Lytic Replication-Defective Kaposi's Sarcoma-Associated Herpesvirus: Potential Role in Infection and Malignant Transformation. J. Virol.
78: 11108-11120
[Abstract]
[Full Text]
-
Krug, L. T., Pozharskaya, V. P., Yu, Y., Inoue, N., Offermann, M. K.
(2004). Inhibition of Infection and Replication of Human Herpesvirus 8 in Microvascular Endothelial Cells by Alpha Interferon and Phosphonoformic Acid. J. Virol.
78: 8359-8371
[Abstract]
[Full Text]
-
Staudt, M. R., Kanan, Y., Jeong, J. H., Papin, J. F., Hines-Boykin, R., Dittmer, D. P.
(2004). The Tumor Microenvironment Controls Primary Effusion Lymphoma Growth in Vivo. Cancer Res.
64: 4790-4799
[Abstract]
[Full Text]
-
Berezne, A., Agbalika, F., Oksenhendler, E., Casper, C., Nichols, W. G., Huang, M.-L., Corey, L., Wald, A.
(2004). Failure of cidofovir in HIV-associated multicentric Castleman disease. Blood
103: 4368-4369
[Full Text]
-
Fakhari, F. D., Dittmer, D. P.
(2002). Charting Latency Transcripts in Kaposi's Sarcoma-Associated Herpesvirus by Whole-Genome Real-Time Quantitative PCR. J. Virol.
76: 6213-6223
[Abstract]
[Full Text]
-
Curreli, F., Cerimele, F., Muralidhar, S., Rosenthal, L. J., Cesarman, E., Friedman-Kien, A. E., Flore, O.
(2002). Transcriptional Downregulation of ORF50/Rta by Methotrexate Inhibits the Switch of Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 from Latency to Lytic Replication. J. Virol.
76: 5208-5219
[Abstract]
[Full Text]
-
Lagunoff, M., Bechtel, J., Venetsanakos, E., Roy, A.-M., Abbey, N., Herndier, B., McMahon, M., Ganem, D.
(2002). De Novo Infection and Serial Transmission of Kaposi's Sarcoma-Associated Herpesvirus in Cultured Endothelial Cells. J. Virol.
76: 2440-2448
[Abstract]
[Full Text]
-
Paulose-Murphy, M., Ha, N.-K., Xiang, C., Chen, Y., Gillim, L., Yarchoan, R., Meltzer, P., Bittner, M., Trent, J., Zeichner, S.
(2001). Transcription Program of Human Herpesvirus 8 (Kaposi's Sarcoma-Associated Herpesvirus). J. Virol.
75: 4843-4853
[Abstract]
[Full Text]
-
Davis, D. A., Rinderknecht, A. S., Zoeteweij, J. P., Aoki, Y., Read-Connole, E. L., Tosato, G., Blauvelt, A., Yarchoan, R.
(2001). Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus. Blood
97: 3244-3250
[Abstract]
[Full Text]
-
Zoeteweij, J. P., Moses, A. V., Rinderknecht, A. S., Davis, D. A., Overwijk, W. W., Yarchoan, R., Orenstein, J. M., Blauvelt, A.
(2001). Targeted inhibition of calcineurin signaling blocks calcium-dependent reactivation of Kaposi sarcoma-associated herpesvirus. Blood
97: 2374-2380
[Abstract]
[Full Text]
-
Jenner, R. G., Albà, M. M., Boshoff, C., Kellam, P.
(2001). Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Gene Expression as Revealed by DNA Arrays. J. Virol.
75: 891-902
[Abstract]
[Full Text]
-
Mercader, M., Taddeo, B., Panella, J. R., Chandran, B., Nickoloff, B. J., Foreman, K. E.
(2000). Induction of HHV-8 Lytic Cycle Replication by Inflammatory Cytokines Produced by HIV-1-Infected T Cells. Am. J. Pathol.
156: 1961-1971
[Abstract]
[Full Text]
-
Alvarez-Barrientos, A., Arroyo, J., Canton, R., Nombela, C., Sanchez-Perez, M.
(2000). Applications of Flow Cytometry to Clinical Microbiology. Clin. Microbiol. Rev.
13: 167-195
[Abstract]
[Full Text]